BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35917337)

  • 21. Multimorbidity in Māori and Pacific patients: cross-sectional study in a Dunedin general practice.
    Stokes T; Azam M; Noble FD
    J Prim Health Care; 2018 Mar; 10(1):39-43. PubMed ID: 30068450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of physical multimorbidity, mental health conditions and socioeconomic deprivation on unplanned admissions to hospital: a retrospective cohort study.
    Payne RA; Abel GA; Guthrie B; Mercer SW
    CMAJ; 2013 Mar; 185(5):E221-8. PubMed ID: 23422444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the Extent of Polypharmacy and its Association With Health Service Utilization Among Persons With Cancer and Multimorbidity: A Population-Based Retrospective Cohort Study in Ontario, Canada.
    Dean T; Koné A; Martin L; Armstrong J; Sirois C
    J Pharm Pract; 2024 Feb; 37(1):35-46. PubMed ID: 35861340
    [No Abstract]   [Full Text] [Related]  

  • 24. Social support, social context and nonadherence to treatment in young senior patients with multimorbidity and polypharmacy followed-up in primary care. MULTIPAP Study.
    Lozano-Hernández CM; López-Rodríguez JA; Leiva-Fernández F; Calderón-Larrañaga A; Barrio-Cortes J; Gimeno-Feliu LA; Poblador-Plou B; Cura-González ID;
    PLoS One; 2020; 15(6):e0235148. PubMed ID: 32579616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional limitation in the older Brazilian adults: Association with multimorbidity and socioeconomic conditions.
    Lopes Vieira MM; Borges VS; Oliveira EJP; Bof de Andrade F
    PLoS One; 2023; 18(11):e0294935. PubMed ID: 38032910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy.
    Rieckert A; Trampisch US; Klaaßen-Mielke R; Drewelow E; Esmail A; Johansson T; Keller S; Kunnamo I; Löffler C; Mäkinen J; Piccoliori G; Vögele A; Sönnichsen A
    BMC Fam Pract; 2018 Jul; 19(1):113. PubMed ID: 30021528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Socioeconomic inequalities in physical, psychological, and cognitive multimorbidity in middle-aged and older adults in 33 countries: a cross-sectional study.
    Ni Y; Zhou Y; Kivimäki M; Cai Y; Carrillo-Larco RM; Xu X; Dai X; Xu X
    Lancet Healthy Longev; 2023 Nov; 4(11):e618-e628. PubMed ID: 37924843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The contribution of risk factors to socioeconomic inequalities in multimorbidity across the lifecourse: a longitudinal analysis of the Twenty-07 cohort.
    Katikireddi SV; Skivington K; Leyland AH; Hunt K; Mercer SW
    BMC Med; 2017 Aug; 15(1):152. PubMed ID: 28835246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is polypharmacy beneficial or detrimental for older adults with cardiometabolic multimorbidity? Pooled analysis of studies from Hong Kong and Europe.
    Cheung JTK; Yu R; Woo J
    Fam Pract; 2020 Nov; 37(6):793-800. PubMed ID: 32596732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations between Polypharmacy, Self-Rated Health, and Depression in African American Older Adults; Mediators and Moderators.
    Bazargan M; Smith J; Saqib M; Helmi H; Assari S
    Int J Environ Res Public Health; 2019 May; 16(9):. PubMed ID: 31064059
    [No Abstract]   [Full Text] [Related]  

  • 31. The influence of childhood socioeconomic status on non-communicable disease risk factor clustering and multimorbidity among adults in Botswana: a life course perspective.
    Keetile M; Letamo G; Navaneetham K
    Int Health; 2023 Jan; 15(1):1-9. PubMed ID: 35512692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Life-course socioeconomic factors are associated with markers of epigenetic aging in a population-based study.
    Petrovic D; Carmeli C; Sandoval JL; Bodinier B; Chadeau-Hyam M; Schrempft S; Ehret G; Dhayat NA; Ponte B; Pruijm M; Vineis P; Gonseth-Nusslé S; Guessous I; McCrory C; Bochud M; Stringhini S
    Psychoneuroendocrinology; 2023 Jan; 147():105976. PubMed ID: 36417838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65 years of age: a longitudinal study.
    Villén N; Guisado-Clavero M; Fernández-Bertolín S; Troncoso-Mariño A; Foguet-Boreu Q; Amado E; Pons-Vigués M; Roso-Llorach A; Violán C
    BMC Geriatr; 2020 Jun; 20(1):206. PubMed ID: 32532213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of life-course socioeconomic inequalities in adult systemic inflammation: Findings from two cohort studies.
    Carmeli C; Steen J; Petrovic D; Lepage B; Delpierre C; Kelly-Irving M; Bochud M; Kivimäki M; Vineis P; Stringhini S
    Soc Sci Med; 2020 Jan; 245():112685. PubMed ID: 31783227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England.
    Tan YY; Papez V; Chang WH; Mueller SH; Denaxas S; Lai AG
    Lancet Healthy Longev; 2022 Oct; 3(10):e674-e689. PubMed ID: 36150402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of parity number with multimorbidity and polypharmacy among Iranian women in the Azarcohort: a cross-sectional study.
    Faramarzi E; Somi MH; Tutunchi H; Almaspour H; Sanaie S; Asemani S
    BMC Womens Health; 2023 Jun; 23(1):295. PubMed ID: 37264361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and predictors of potentially inappropriate prescribing in middle-aged adults: a repeated cross-sectional study.
    Khatter A; Moriarty F; Ashworth M; Durbaba S; Redmond P
    Br J Gen Pract; 2021 Jul; 71(708):e491-e497. PubMed ID: 33606659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy.
    Whitney DG; Schmidt M; Haapala H
    J Manag Care Spec Pharm; 2021 Jan; 27(1):51-63. PubMed ID: 33377441
    [No Abstract]   [Full Text] [Related]  

  • 40. Childhood Conditions and Multimorbidity Among Older Adults.
    Pavela G; Latham K
    J Gerontol B Psychol Sci Soc Sci; 2016 Sep; 71(5):889-901. PubMed ID: 25975290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.